Background: ASSURE-CSU revealed differences in physician and patient reporting
angioedema data from medical records, which were compared with patient-reported data. Patients in the Yes-angioedema category had angioedema reported in the medical record and a patient-reported source. For those in the No-angioedema category, angioedema was reported in neither the medical record nor a patient-reported source. Those in the Misaligned category had angioedema reported in only one source. Statistical comparisons between Yes-angioedema and No-angioedema categories were conducted for measures of CSU activity, health-related quality of life (HRQoL), productivity and healthcare resource utilization (HCRU). Regression analyses explored the relationship between Dermatology Life Quality Index (DLQI) score and angioedema, adjusting for important covariates.
Results: Among evaluable patients, 259 (40.3%), 173 (26.9%) and 211 (32.8%) were in the Yes-angioedema, No-angioedema and Misaligned category, respectively. CSU activity and impact on HRQoL, productivity, and HCRU was greater for Yes-angioedema patients than No-angioedema patients. After covariate adjustment, mean DLQI score was significantly higher (indicating worse HRQoL) for patients with angioedema versus no angioedema (9.88 vs 7.27, P < .001). The Misaligned category had similar results with Yes-angioedema on all outcomes.
Conclusions: Angioedema in CSU seems to be under-reported but has significant negative impacts on HRQoL, daily activities, HCRU and work compared with no angioedema.
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| INTRODUCTION
Chronic spontaneous urticaria (CSU) is characterized by the presence of hives, angioedema or both, recurring for 6 weeks or longer, in the absence of identifiable triggers. 1, 2 Angioedema is defined as rapid swelling at a deeper level under the skin than hives, occurring on the face, inside the mouth or elsewhere on the body. 2, 3 It is estimated that 33%-67% of patients with CSU exhibit both hives and angioedema, 29%-65% exhibit only hives and 1%-13% exhibit only angioedema. 4, 5 Patients who experience CSU as concurrent hives and angioedema often experience a longer duration of disease than patients who experience only hives. 6, 7 Angioedema may be disfiguring or painful, may limit daily activities and may have a significant impact on quality of life. 8, 9 Patients with CSU-associated angioedema often experience concern over their health status, at times worrying that swelling episodes may cause problems with breathing or may be lifethreatening. 9 A real-world multicentre study in Germany has shown that in a 6-month period, more than 40% of patients with inadequately controlled CSU experienced angioedema; among these patients, 78% rated their angioedema as severe or moderate in intensity, and a mean of 34 days with angioedema was reported during the 6-month period. 5 In addition to its considerable symptom burden, recurrent angioedema (in those with hereditary angioedema) can lead to absenteeism and can have a negative impact on work productivity. 10 The observational, multinational ASSURE-CSU (ASsessment of Regression modelling was used to explore whether the relationship between DLQI score and angioedema remained significant after adjusting for important covariates. An analysis of covariance model was used to evaluate the effect of angioedema on DLQI total score.
Adjustment covariates included UAS7 TD score, age, sex, country, disease duration from diagnosis to enrolment and selected comorbidities at enrolment (hypersensitivity to nonsteroidal anti-inflammatory drugs, Hashimoto's disease and asthma). UAS7 TD score, age and disease duration were treated as continuous variables. Least-squares mean estimates and standard errors were estimated for each angioedema classification; patients in the Misaligned category were combined with patients in the Yes-angioedema category for the primary analysis. A sensitivity analysis was also conducted in which the 
| Postalignment angioedema frequency over the past 12 months
Of the 673 patients enrolled, 643 patients had recorded data for assigning the angioedema classification, and 30 patients had missing data either in the MRA or from both patient data sources (survey and diary) and could not be classified. Figure 1B ; Table S1 ).
| Patient demographics
There were no significant differences in baseline characteristics between patients in the Yes-angioedema and No-angioedema categories, except in duration of CSU and presence of Hashimoto's disease ( Figure 3A ). Significant differences were observed between patients with and without angioedema on all CU-Q 2 oL domains.
| Urticaria severity and activity
On the DLQI, mean (SD) overall score for the entire sample was 9.1 (6.63) and for Yes-angioedema and No-angioedema groups were 10.4 (6.85) and 6.6 (5.21), respectively (P < .001) ( Figure 3B ). Again, significant differences were observed between patients with and without angioedema on all DLQI domains ( Figure 3C ). More patients in the Yes-angioedema category (45.5%) than in the No-angioedema Figure 3D ). Activity impairment measured by the mean percentage overall activity impairment score on the WPAI was also greater for patients in the Yes-angioedema category than for patients in the Noangioedema category (34.5% vs 23.8%; P < .001) (Figure 4 ).
| Economic and societal impact of angioedema
Patients in the Yes-angioedema category had greater HCRU, both documented in medical records and self-reported, than patients in the No-angioedema category (Table S2 ). According to the MRA, patients in the Yes-angioedema category were more likely to have a CSU-related emergency department visit than patients in the Noangioedema category (24.7% vs 5.2%, P < .001) and were more likely to have one or more inpatient hospital stays in the past 12 months (11.6% vs 3.5%, P < .01). As reported in the patient diary, patients with angioedema were more likely to call a healthcare provider during the 7-day window than patients without angioedema (7.3% vs 0.6%, P < .01). (Figure 4 ).
Impact on work was greater among patients in the

| DLQI regression analysis
Given the similarities in characteristics and outcomes among patients in the Misaligned and Yes-angioedema categories, the Misaligned patients were combined with the Yes-angioedema patients in the primary regression analysis of DLQI total score. After covariate adjustment, mean DLQI score was significantly higher for patients with angioedema versus without (9.88 vs 7.27, P < .001) ( Table 2) .
Results were similar in the sensitivity analysis in which patients in the Misaligned angioedema category were excluded: mean DLQI total score was significantly higher for patients with angioedema versus without (9.69 vs 6.73, P < .001).
F I G U R E 2 Mean urticaria activity score over 7 days, twice-daily assessment (UAS7 TD ), by angioedema classification. UAS7 TD scores were calculated by summing the average of twice-daily assessments of hive count and itch score and summing these daily scores over 7 days. *P < . The primary ASSURE-CSU analysis found that angioedema had a significant impact on HRQoL in patients with CSU, particularly with respect to emotional well-being, fatigue and mood. 12 The current analysis also revealed the considerable impact of angioedema on HRQoL, as indicated by CU-Q 2 oL and DLQI scores, and its additional negative impact on top of itch and hives. Even after controlling for other factors, angioedema has a significant effect on the DLQI total score. In addition, patients with angioedema have additional impairment on work productivity and more HCRU than those without it, indicating that angioedema further contributes to the economic burden of inadequately controlled CSU.
Taken together, findings from these analyses suggest that physicians should ensure that patients understand the manifestations of angioedema and should routinely assess patients with CSU for presence of angioedema, which may enable more accurate estimates of the true prevalence and burden of angioedema.
Appropriate tools available for evaluating angioedema activity and its impact on CSU patients' lives should be used regularly in clinical practice. [22] [23] [24] In patients with recurrent angioedema, CSU should be considered as one of the differential diagnoses. 1, 25 Additionally, angioedema in CSU should prompt adequate treatment. The development of new treatments specifically for CSU has been shown to prevent angioedema and improve angioedemadependent and dermatology-related quality of life. In addition, data extracted by physicians from medical records were not independently validated.
| CONCLUSION S
Among this study population with inadequately controlled CSU, 40.3% had confirmed angioedema in the past 12 months, and 32.8% Patients with angioedema reported statistically significantly worse HRQoL and higher societal burden than patients without angioedema; patients in the Misaligned group reported similar impairment as patients with confirmed angioedema. Overall, the study found that angioedema has an incremental impact on societal and humanistic outcomes in CSU patients. These findings suggest the need for improved physician-patient communication regarding angioedema for better symptom control in patients with inadequately controlled CSU.
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